The initial agreement is for a term of 3 years. Annual renewal is available after the initial term expires.
Description
INCELL has developed proprietary anti-HHV-8 and other monoclonal antibody (mAb)-producing cell lines. Details can be provided on request.
INCELL can develop client-customized mAb producing cell lines.
